Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

FDA Too Quick to Call BPA Chemical Safe, Health Experts Say

Posted 23 Oct 2018 by Drugs.com

TUESDAY, Oct. 23, 2018 – The U.S. Food and Drug Administration "jumped the gun" when it declared the chemical BPA safe for consumers earlier this year, experts from the Endocrine Society claimed Tuesday. The FDA asserted in February that its "initial review supports our determination that currently authorized uses of BPA continue to be safe for consumers." But the FDA made that statement without ...

Health Tip: Identifying Risk Factors for Prostate Cancer

Posted 14 Sep 2018 by Drugs.com

-- Prostate cancer is rare in men younger than 40, but as a man reaches 50, his chances of getting the disease increase. About 6 in 10 prostate cancers are found in men older than 65, the American Cancer Society says. The ACS mentions these risk factors for prostate cancer: Age. Ethnicity: Prostate cancer occurs more often in black men and Caribbean men of African ancestry than in men of other ...

Is Teen Drinking Tied to Aggressive Prostate Cancer Later in Life?

Posted 29 Aug 2018 by Drugs.com

WEDNESDAY, Aug. 29, 2018 – Teen boys who drink may raise their risk for aggressive prostate cancer decades later, a preliminary study suggests. Compared to non-drinkers, men who reported having at least one alcoholic drink a day between ages 15 and 19 had more than triple the odds of developing aggressive prostate cancer in adulthood, the researchers said. The study doesn't prove that alcohol ...

Health Tip: Talking About Your Cancer Diagnosis

Posted 28 Aug 2018 by Drugs.com

-- If you've been diagnosed with cancer, your family and close friends can be a great source of physical and moral support. The American Cancer Society suggests how to tell loved ones about your diagnosis: Don't wait to tell them. Sooner or later, they'll all know. They might feel hurt or left out if they haven't heard about it from you. Explain what type of cancer you have and how it will be ...

Too Few Americans Getting Screened for Cancer: CDC

Posted 26 Jul 2018 by Drugs.com

THURSDAY, July 26, 2018 – Routine checks for breast, prostate, cervical and colon cancer save lives, but screening rates for all but colon cancer have stalled in recent years, U.S. health officials report. According to the new U.S. Centers for Disease Control and Prevention study, the number of Americans getting recommended cancer screening remains below target levels. This is especially the ...

Large U.S. Study Targets Prostate Cancer in Black Men

Posted 23 Jul 2018 by Drugs.com

MONDAY, July 23, 2018 – Black men in the United States have higher rates of aggressive prostate cancer than other males. Now, a $26.5 million study is underway to figure out why. The U.S. National Institutes of Health and the Prostate Cancer Foundation have launched the study to investigate social, environmental and genetic factors behind this disparity. "No group in the world is hit harder by ...

Could an Early Supper Lower Breast, Prostate Cancer Risk?

Posted 18 Jul 2018 by Drugs.com

WEDNESDAY, July 18, 2018 – Having a late dinner and heading straight to bed may boost your risk of breast or prostate cancer, a new study suggests. Spanish researchers analyzed data from 621 prostate cancer patients and 1,205 breast cancer patients, as well as 872 men and 1,321 women without these cancers. People who ate their evening meal before 9 p.m. or waited at least two hours after supper ...

FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)

Posted 16 Jul 2018 by Drugs.com

TOKYO and NEW YORK, July 13, 2018 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for Xtandi (enzalutamide), following FDA Priority Review designation, based on results from the Phase 3 PROSPER trial. The ...

Could Targeted Drug Enzalutamide Help Keep Aggressive Prostate Cancer in Check?

Posted 27 Jun 2018 by Drugs.com

WEDNESDAY, June 27, 2018 – Men with localized high-risk prostate cancer can slow its spread by using a cancer drug that's already on the market, a new clinical trial shows. The targeted drug enzalutamide (Xtandi) reduced by 71 percent these men's risk of either dying from their prostate cancer or having the cancer spread to other organs, compared against a placebo. The drug also delayed their ...

New DNA Test May Predict Prostate Cancer Risk

Posted 11 Jun 2018 by Drugs.com

MONDAY, June 11, 2018 – A new genetic test can identify men most likely to develop prostate cancer, a new report contends. According to the new study, the scientists identified 63 new genetic variants associated with increased risk of prostate cancer, and combined them with more than 100 previously identified variants to create the new test. The test identifies the 1 percent of men who are at ...

Blacks With Prostate Cancer May Fare Better Than Whites

Posted 1 Jun 2018 by Drugs.com

FRIDAY, June 1, 2018 – Black men with advanced prostate cancer who get chemotherapy may live longer than white men, a new study suggests. Data from nine trials including more than 8,000 men with advanced prostate cancer showed that survival for black men was initially the same as for white men – an average of 21 months. But after taking into account other factors – such as site of the cancer ...

Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer

Posted 24 May 2018 by Drugs.com

MUMBAI & PRINCETON, N.J. & KING OF PRUSSIA, Pa. May 23, 2018 --(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. and includes its subsidiaries and/or associate companies) and Churchill Pharmaceuticals, LLC. (Churchill) today announced that one of Sun Pharma’s wholly owned subsidiary companies has received approval from the U.S. Food and Drug Administration (FDA) for Yonsa (abiraterone acetate), ...

U.S. Cancer Death Rate Declines Again, But Prostate Cancer Incidence Rises

Posted 22 May 2018 by Drugs.com

TUESDAY, May 22, 2018 – There's good news for Americans in the war against cancer. Cancer deaths continue to decline nationwide, according to the Annual Report to the Nation on the Status of Cancer. But the report also points to one troubling trend – prostate cancer deaths are creeping up again after years of decline, suggesting that controversy over the best way to screen for the disease may ...

Expert Panel Highlights Patient Choice for Prostate Cancer Screen

Posted 8 May 2018 by Drugs.com

TUESDAY, May 8, 2018 – More men could receive PSA blood tests for prostate cancer under revised guidelines released Tuesday by the nation's leading panel on preventive medicine. The U.S. Preventive Services Task Force (USPSTF) now recommends that men aged 55 to 69 decide for themselves whether to undergo a prostate-specific antigen (PSA) test, after talking it over with their doctor. This blood ...

Could a Tattoo Someday Spot Your Cancer?

Posted 19 Apr 2018 by Drugs.com

THURSDAY, April 19, 2018 – Tattoos serve many purposes, perhaps expressing artistry, loyalty or love. Now, scientists working with mice say they've engineered a medical "tattoo" that can screen for early signs of major disease. The biomedical tattoo is made up of cells embedded with sensors that measure levels of blood calcium. It's initially invisible when implanted under the skin. But the ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

estradiol, Premarin, Estrace, Lupron Depot, ethinyl estradiol, Zoladex, Zytiga, Estradiol Patch, Casodex, view more... Xtandi, Eligard, capecitabine, flax, Taxotere, bicalutamide, Cenestin, degarelix, Menest, Progynova, Enjuvia, Erleada, Trelstar LA, Flax Seed Oil, Firmagon, Trelstar, Supprelin LA, Yonsa, cyclophosphamide, leuprolide, abiraterone, esterified estrogens, goserelin, Plenaxis, flutamide, Oromone, Provames, Systen, Thais, Thaissept, Stilphostrol, estramustine, Premarin Intravenous, Estratab, histrelin, Provenge, Jevtana, docetaxel, Docefrez, diethylstilbestrol, Xofigo, Zoladex 3-Month, Primogyn Depot, Sandrena, Zumenon, Novantrone, apalutamide, radium 223 dichloride, enzalutamide, cabazitaxel, Delestrogen, Emcyt, sipuleucel-t, Vantas, aminoglutethimide, Nilandron, Cytadren, Trelstar Depot, conjugated estrogens, Viadur, triptorelin, nilutamide, mitoxantrone, Estinyl, Eulexin, Valergen, Progynova TS, abarelix